The Interventional Oncology Center

Filter Your Results

 

News

 

Terumo’s HydroPearl and LifePearl Microspheres Approved in Europe

April 2, 2015 -- Terumo announced that European CE Mark approval for two new products was received last month. The HydroPearl is a new Terumo microsphere for more predictable …

Sirtex Reports Preliminary SIRFLOX Study Results

March 17, 2015 -- Sirtex Medical Limited reported the preliminary results of its SIRFLOX clinical study of the company’s SIR-Spheres Y-90 resin microspheres in the …

Study of Y-90 Radioembolization Using Glass Microspheres Presented

March 4, 2015 -- Findings from a study that aimed to evaluate survival and safety outcomes for patients with hepatic metastases of colorectal cancer treated with yttrium-90 (Y…

Prostate Artery Embolization Shown to Be Effective for Benign Prostatic Hyperplasia in Study Presented at SIR

March 2, 2015 -- The Society of Interventional Radiology (SIR) announced that a retrospective study of treating benign prostatic hyperplasia (BPH) using prostate artery emboli…

Sirtex Completes Enrollment in FOXFIRE and FOXFIRE Global Studies

January 29, 2015 -- Sirtex Medical Limited announced the completion of patient enrollment in the FOXFIRE and FOXFIRE Global studies of the addition of liver-directed radiation…

Enrollment Begins for CIRSE Registry of SIR-Spheres to Treat Liver Cancer

January 19, 2015 -- The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched the CIRSE Registry for SIR‐Spheres Therapy (CIRT). This is a si…

CE Mark Indication Expanded for CeloNova’s Embozene Microspheres

January 14, 2015 -- CeloNova BioSciences, Inc. announced that it has received an expanded indication to its CE Mark approval in Europe for its Embozene embolic microspheres to…

Hansen Medical’s Magellan System Used for First Robotic PAE Procedure in the United States

November 20, 2014 -- Hansen Medical, Inc. announced the completion of the first robotic prostatic artery embolization (PAE) in the United States. Interventional radiologist Sa…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.